Investigating metabolic characteristics of type 2 diabetes mellitus-related cognitive dysfunction and correlating therapeutic effects of Di Dang Tang in animal models

被引:0
|
作者
Sheng, Changting [1 ]
Yue, Rensong [1 ]
机构
[1] Hosp Chengdu Univ Tradit Chinese Med, Chengdu, Sichuan, Peoples R China
基金
中国国家自然科学基金;
关键词
Type; 2; diabetes; Cognitive dysfunction; Di dang tang; Metabolomics; Hippocampus; INSULIN-RESISTANCE; NERVOUS-SYSTEM; INFLAMMATION; DECLINE;
D O I
10.1016/j.jep.2025.119338
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Ethnopharmacological relevance: Di Dang Tang is a classic formula from Shang Han Lun, originally used to treat conditions such as blood stasis and heat accumulation. It is widely applied in the treatment of diabetes and its complications, but its effects on Type 2 Diabetes Mellitus-related Cognitive Dysfunction (T2DM-CD) remain unclear. Aim of the study: The study aimed to investigate the metabolic characteristics of patients with T2DM-CD. Additionally, it sought to evaluate the effects of Di Dang Tang on cognitive function in T2DM-CD model rats by targeting the metabolic pathways identified in the clinical analysis, exploring the underlying mechanisms through animal experiments. Methods: Fasting venous serum was collected from patients with Type 2 Diabetes Mellitus (T2DM) to detect metabolism-related products, and KEGG annotation analysis was performed. Separately, thirty rats were randomly divided using a random number table method, with six rats selected as the blank control group. Twenty-four successfully modeled rats were then randomly divided into the model group and three Di Dang Tang groups (low, medium, and high doses). After administering the medication, the relevant indicators in the rats were assessed. Results: Clinical metabolomics detected 32 key differential metabolites between the T2DM-CD and the blank control groups. Between the T2DM-CD and T2DM groups, 29 key differential metabolites were identified. In animal experiments, blood glucose levels in the model group were significantly higher compared to the blank control group at the same time points, whereas the high dose groups of Di Dang Tang exhibited reduced blood glucose levels at weeks 6 and 8 relative to the model group. In the Morris water maze test, the model group had longer escape latencies than the blank control group. The medium and high dose groups of Di Dang Tang showed shorter latencies. Additionally, compared to the model group, the Di Dang Tang groups spent more time and covered more distance in the target quadrant but had reduced average proximity and fewer platform entries. HE staining observation of the hippocampal CA1 area showed no apparent pathological changes in the blank group, obvious pathological damage in the model group, and no significant pathological changes in the medium and high dose groups of Di Dang Tang. Compared to the blank control group, the model group showed significant increases in the levels of Arachidonic Acid (AA), Ceramide (Cer), Glutamate (Glu), TNF- alpha, IL-1 beta, TG, and LDL-C, and a significant decrease in HDL-C levels. Compared to the model group, the groups of Di Dang Tang significantly modulated the levels of the above indicators. In Western Blot (WB) assays, compared to the blank control group, the model group rats exhibited significantly higher levels of cPLA2, PKC, ERK, and JNK , and significantly lower levels of claudin-5, NMDA, CaMKII, CREB, and BDNF. The Di Dang Tang groups significantly altered the levels of the above indicators compared to the model group. Conclusion: Amino acid metabolism, sphingolipid signaling pathways, glycerophospholipid metabolism, and various signaling pathways play significant roles in the pathogenesis of T2DM-CD. Di Dang Tang can improve learning and memory abilities in T2DM model rats and ameliorate cognitive impairments, potentially by regulating metabolic levels and inflammatory responses.
引用
收藏
页数:21
相关论文
共 43 条
  • [21] Effects of living arrangements and cognitive function on blood pressure and metabolic control in older patients with type 2 diabetes mellitus
    Furuhashi, N.
    Hirose, T.
    Kuroda, M.
    Kimura, M.
    Furuta, T.
    Sarui, H.
    Takeda, N.
    JOURNAL OF HYPERTENSION, 2006, 24 : S130 - S130
  • [22] Alzheimer's disease and type 2 diabetes mellitus are distinct diseases with potential overlapping metabolic dysfunction upstream of observed cognitive decline
    Chornenkyy, Yevgen
    Wang, Wang-Xia
    Wei, Angela
    Nelson, Peter T.
    BRAIN PATHOLOGY, 2019, 29 (01) : 3 - 17
  • [23] Effects of living arrangements and cognitive function on blood pressure and metabolic control in older patients with type 2 diabetes mellitus
    Furuhashi, N
    Hirose, T
    Kuroda, M
    Kimura, M
    Ishizawa, M
    Sarui, H
    Takeda, N
    Furuta, T
    JOURNAL OF HYPERTENSION, 2004, 22 : S222 - S223
  • [24] Hepatic steatosis contributes to cognitive impairment in patients with metabolic dysfunction-associated steatotic liver disease and/or type 2 diabetes-mellitus
    del Campo, Nuria Perez Diaz
    Ferro, Arianna
    Castelnuovo, Gabriele
    Caviglia, Gian Paolo
    Rosso, Chiara
    Guariglia, Marta
    Dileo, Eleonora
    Armandi, Angelo
    Saba, Francesca
    Saracco, Giorgio Maria
    Barutta, Federica
    Beccuti, Guglielmo
    Gruden, Gabriella
    Bugianesi, Elisabetta
    JOURNAL OF HEPATOLOGY, 2024, 80 : S483 - S483
  • [25] Aerobic Exercise Improves Type 2 Diabetes Mellitus-Related Cognitive Impairment by Inhibiting JAK2/STAT3 and Enhancing AMPK/SIRT1 Pathways in Mice
    Lin, Lili
    Wang, Yonghua
    Xu, Wenli
    Huang, Chaolu
    Hu, Jinrong
    Chen, Xixi
    Lv, Xinhuang
    Qin, Yuelin
    Zhao, Xiaoyong
    Li, Haiyan
    DISEASE MARKERS, 2022, 2022
  • [26] Effects of Metformin on Bone Mineral Density and Adiposity-Associated Pathways in Animal Models with Type 2 Diabetes Mellitus: A Systematic Review
    Loh, Darren Kin Wai
    Kadirvelu, Amudha
    Pamidi, Narendra
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (14)
  • [27] Patient characteristics related to metabolic disorders and chronic complications in type 2 diabetes mellitus patients hospitalized at the Qingdao Endocrine and Diabetes Hospital from 2006 to 2012 in China
    Dong, Yanhu
    Zhang, Lei
    Gao, Weiguo
    Wang, Na
    Wei, Jia
    Hammar, Niklas
    Cabrera, Claudia
    Qiao, Qing
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2015, 31 : 18 - 19
  • [28] Patient characteristics related to metabolic disorders and chronic complications in type 2 diabetes mellitus patients hospitalized at the Qingdao Endocrine and Diabetes Hospital from 2006 to 2012 in China
    Dong, Yanhu
    Gao, Weiguo
    Zhang, Lei
    Wei, Jia
    Hammar, Niklas
    Cabrera, Claudia S.
    Wu, Xiaoli
    Qiao, Qing
    DIABETES & VASCULAR DISEASE RESEARCH, 2017, 14 (01): : 24 - 32
  • [29] Epidemiology of Metabolic Dysfunction-Associated Fatty Liver Disease in Type 2 Diabetes Mellitus and Effects of Antiglycemic Therapy on Liver Fibrosis: A Retrospective Study
    Butt, Muhammad Imran
    Puri, Gaurav
    Berkman, Kathryn
    Ryder, Simon
    Knowles, Joshua
    Shahzad, Muhammad Asif
    Malik, Muhammad Amer
    Shalev, Noa
    Sexton, Jo
    JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2024, 14 (02) : 63 - 70
  • [30] Olivetol's Effects on Metabolic State and Gut Microbiota Functionality in Mouse Models of Alimentary Obesity, Diabetes Mellitus Type 1 and 2, and Hypercholesterolemia
    Zabolotneva, Anastasia A.
    Popruga, Katerina E.
    Makarov, Valentin V.
    Yudin, Sergei M.
    Gaponov, Andrei M.
    Roumiantsev, Sergei A.
    Shestopalov, Aleksandr V.
    BIOMEDICINES, 2025, 13 (01)